A North Dakota-specific peptide guide connecting seller and pharmacy claims to the state's official license route while keeping prescription, compounding, and laboratory research categories separate.
US research listing snapshotCompare 7 current BPC-157 listingsExact-size public listings kept separate from clinics and pharmacies.↓In North Dakota, a local address, shipment promise, clinic page, or pharmacy name is only a starting claim. North Dakota Board of Pharmacy provides a board-operated verification route for pharmacy and pharmacist records, while federal product and compounding records answer separate questions.
Use this checklist to verify the local product, seller, and supply records before comparing price or availability.
Use board of pharmacy license verification to match the legal name, license type, address, and current status behind a pharmacy, professional, or facility claim involving North Dakota.
A North Dakota credential does not approve every product, ingredient, presentation, compounding basis, prescription route, or delivery claim. Check the applicable FDA record independently.
Keep prescription care, compounded preparations, telehealth services, and laboratory research listings in separate lanes. For market rows, compare the same nominal size, availability date, shipping basis, and evidence access.
Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓
No blanket answer is supportable. Use board of pharmacy license verification to match the legal name, license type, address, and current status behind a pharmacy, professional, or facility claim involving North Dakota. In North Dakota, begin with Board of Pharmacy license verification from North Dakota Board of Pharmacy; the product, seller, and supply route still need to resolve to the same current record.
No. In North Dakota, the 78 us listings / 20 boards shown here are national laboratory-research catalog observations ordered by availability and public list price at a matched nominal size. They do not rank local pharmacies, clinics, prescription access, medical suitability, safety, or quality.
For North Dakota, start with Board of Pharmacy license verification from North Dakota Board of Pharmacy, then open Locate a state-licensed online pharmacy from U.S. Food and Drug Administration. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.
Each answer preserves the compound’s research, clinical, or medicine identity and then points to the official North Dakota verification route. A shared name or state license is not a blanket product, seller, legal, or availability finding.
KPV in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗BPC-157 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗TB-500 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗GHK-Cu in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Semax in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Melanotan II in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗MOTS-c in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Tesamorelin in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗AOD-9604 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Ipamorelin in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Selank in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗PT-141 / Bremelanotide in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗CJC-1295 no DAC in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗CJC-1295 DAC in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Retatrutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Mazdutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Ecnoglutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Enicepatide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Eloralintide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Cagrilintide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Petrelintide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗CagriSema in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗MariTide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Survodutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗VK2735 in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Pemvidutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Amycretin / Zenagamtide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Tirzepatide in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Orforglipron / Foundayo in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Semaglutide in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗DSIP / Emideltide in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗IGF-1 LR3 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Kisspeptin-10 / KP-10 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Melanotan I in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗NAD+ in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Sermorelin in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Thymosin Alpha-1 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗EGRIFTA WR in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗Liraglutide in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗SCENESSE in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗VYLEESI in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy license verificationNorth Dakota Board of Pharmacy ↗These listings are for laboratory research materials. They are not local clinics, pharmacies, or approved products for human use.
Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 10 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Pure Health PeptidesPrice and stock confirmed Jul 27In stock | $40.00Source confirmed | $4.00 | Public lot COA libraryAccess: Public link · Seller claim · Jul 27, 2026 | Free shipping over $175; lower-order rate at checkout | |
02Purgo LabsCurrent public batch reportIn stock | $44.99Source confirmed | $4.50 | Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
03Pepta LabsFree US shipping claimedIn stock | $52.79Source confirmed | $5.28 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
04Prime PeptidesPublic report linkedIn stock | $60.00Source confirmed | $6.00 | Report displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 | |
05Biotech PeptidesPublic size-specific documentsIn stock | $92.00Source confirmed | $9.20 | COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026 | Free USPS Priority over $200; lower-order rate not stated | |
06AminoCore ResearchPrice confirmed; stock not statedStatus not stated | $55.00Source confirmed | $5.50 | COA includedAccess: Included with order · Seller claim · Jul 23, 2026 | Free shipping claimed | |
07Core PeptidesPrice shown; stock label absentStatus not stated | $97.00Source confirmed | $9.70 | COA tab shownAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.